@article{35f3b666d9794bbcb40538f356068b2d,
title = "Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer The ROPETAR Randomized Clinical Trial",
keywords = "PHASE-III TRIAL, SUNITINIB RECHALLENGE, DRUG-RESISTANCE, CARCINOMA, THERAPY, SURVEILLANCE, GUIDELINES, EFFICACY",
author = "Cirkel, {Geert A.} and Paul Hamberg and Stefan Sleijfer and Loosveld, {Olaf J. L.} and Dercksen, {M. Wouter} and Maartje Los and Polee, {Marco B.} and {van den Berkmortel}, Franchette and Aarts, {Maureen J.} and Beerepoot, {Laurens V.} and Gerard Groenewegen and Lolkema, {Martijn P.} and Metin Tascilar and Portielje, {Johanna E. A.} and Peters, {Frank P. J.} and Heinz-Josef Kluempen and {van der Noort}, Vincent and Haanen, {John B. A. G.} and Voest, {Emile E.} and {Dutch WIN-O Consortium}",
year = "2017",
month = apr,
day = "1",
doi = "10.1001/jamaoncol.2016.5202",
language = "English",
volume = "3",
pages = "501--508",
journal = "JAMA Oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "4",
}